(VTVT) |
| 0 (0%) 07-13 23:25 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 38.84 |
| Resistance 1: | 35.62 |
| Pivot price: | 34.87 |
| Support 1: | 30.41 |
| Support 2: | 25.30 |
| 52w High: | |
| 52w Low: |
| EPS | -0.780 |
| Book Value | 7.250 |
| PEG Ratio | 0.00 |
| Gross Profit | 3.256 |
| Profit Margin (%) | 6.11 |
| Operating Margin (%) | 63.15 |
| Return on Assets (ttm) | -2.9 |
| Return on Equity (ttm) | -1.5 |
Sat, 11 Jul 2026
TD Cowen initiates coverage of vTv Therapeutics (VTVT) with buy recommendation - MSN
Sat, 11 Jul 2026
Technical Reactions to VTVT Trends in Macro Strategies - Stock Traders Daily
Thu, 02 Jul 2026
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Thu, 02 Jul 2026
vTv Therapeutics lures two employees with 12,500 stock options - Stock Titan
Tue, 30 Jun 2026
Trading the Move, Not the Narrative: (VTVT) Edition - Stock Traders Daily
Mon, 29 Jun 2026
Director at vTv Therapeutics (VTVT) awarded 6,000 stock options grant - Stock Titan
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |